Random walk-based feature learning for micro-expression recognition

MNCLCDA: predicting circRNA-drug sensitivity associations by using mixed neighbourhood information and contrastive learning

BACKGROUND

circRNAs play an important role in drug resistance and cancer development. Recently, many studies have shown that the expressions of circRNAs in human cells can affect the sensitivity of cells to therapeutic drugs, thus significantly influencing the therapeutic effects of these drugs. Traditional biomedical experiments required to verify this sensitivity relationship are not only time-consuming but also expensive. Hence, the development of an efficient computational approach that can accurately predict the novel associations between drug sensitivities and circRNAs is a crucial and pressing need.

METHODS

In this research, we present a novel computational framework called MNCLCDA, which aims to predict the potential associations between drug sensitivities and circRNAs to assist with medical research. First, MNCLCDA quantifies the similarity between the given drug and circRNA using drug structure information, circRNA gene sequence information, and GIP kernel information. Due to the existence of noise in similarity information, we employ a preprocessing approach based on random walk with restart for similarity networks to efficiently capture the useful features of circRNAs and drugs. Second, we use a mixed neighbourhood graph convolutional network to obtain the neighbourhood information of nodes. Then, a graph-based contrastive learning method is used to enhance the robustness of the model, and finally, a double Laplace-regularized least-squares method is used to predict potential circRNA-drug associations through the kernel matrices in the circRNA and drug spaces.

RESULTS

Numerous experimental results show that MNCLCDA outperforms six other advanced methods. In addition, the excellent performance of our proposed model in case studies illustrates that MNCLCDA also has the ability to predict the associations between drug sensitivity and circRNA in practical situations.

CONCLUSIONS

After a large number of experiments, it is illustrated that MNCLCDA is an efficient tool for predicting the potential associations between drug sensitivities and circRNAs, thereby can provide some guidance for clinical trials.

Graph2MDA: a multi-modal variational graph embedding model for predicting microbe-drug associations

MOTIVATION

Accumulated clinical studies show that microbes living in humans interact closely with human hosts, and get involved in modulating drug efficacy and drug toxicity. Microbes have become novel targets for the development of antibacterial agents. Therefore, screening of microbe-drug associations can benefit greatly drug research and development. With the increase of microbial genomic and pharmacological datasets, we are greatly motivated to develop an effective computational method to identify new microbe-drug associations.

RESULTS

In this article, we proposed a novel method, Graph2MDA, to predict microbe-drug associations by using variational graph autoencoder (VGAE). We constructed multi-modal attributed graphs based on multiple features of microbes and drugs, such as molecular structures, microbe genetic sequences and function annotations. Taking as input the multi-modal attribute graphs, VGAE was trained to learn the informative and interpretable latent representations of each node and the whole graph, and then a deep neural network classifier was used to predict microbe-drug associations. The hyperparameter analysis and model ablation studies showed the sensitivity and robustness of our model. We evaluated our method on three independent datasets and the experimental results showed that our proposed method outperformed six existing state-of-the-art methods. We also explored the meaning of the learned latent representations of drugs and found that the drugs show obvious clustering patterns that are significantly consistent with drug ATC classification. Moreover, we conducted case studies on two microbes and two drugs and found 75-95% predicted associations have been reported in PubMed literature. Our extensive performance evaluations validated the effectiveness of our proposed method.

AVAILABILITY AND IMPLEMENTATION

Source codes and preprocessed data are available at https://github.com/moen-hyb/Graph2MDA.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

FMD-Yolo: An efficient face mask detection method for COVID-19 prevention and control in public

Coronavirus disease 2019 (COVID-19) is a world-wide epidemic and efficient prevention and control of this disease has become the focus of global scientific communities. In this paper, a novel face mask detection framework FMD-Yolo is proposed to monitor whether people wear masks in a right way in public, which is an effective way to block the virus transmission. In particular, the feature extractor employs Im-Res2Net-101 which combines Res2Net module and deep residual network, where utilization of hierarchical convolutional structure, deformable convolution and non-local mechanisms enables thorough information extraction from the input. Afterwards, an enhanced path aggregation network En-PAN is applied for feature fusion, where high-level semantic information and low-level details are sufficiently merged so that the model robustness and generalization ability can be enhanced. Moreover, localization loss is designed and adopted in model training phase, and Matrix NMS method is used in the inference stage to improve the detection efficiency and accuracy. Benchmark evaluation is performed on two public databases with the results compared with other eight state-of-the-art detection algorithms. At IoU = 0.5 level, proposed FMD-Yolo has achieved the best precision AP50 of 92.0% and 88.4% on the two datasets, and AP75 at IoU = 0.75 has improved 5.5% and 3.9% respectively compared with the second one, which demonstrates the superiority of FMD-Yolo in face mask detection with both theoretical values and practical significance.

Predicting human microbe-drug associations via graph convolutional network with conditional random field

Motivation

Human microbes play critical roles in drug development and precision medicine. How to systematically understand the complex interaction mechanism between human microbes and drugs remains a challenge nowadays. Identifying microbe-drug associations can not only provide great insights into understanding the mechanism, but also boost the development of drug discovery and repurposing. Considering the high cost and risk of biological experiments, the computational approach is an alternative choice. However, at present, few computational approaches have been developed to tackle this task.

Results

In this work, we leveraged rich biological information to construct a heterogeneous network for drugs and microbes, including a microbe similarity network, a drug similarity network, and a microbe-drug interaction network. We then proposed a novel Graph Convolutional Network (GCN) based framework for predicting human Microbe-Drug Associations, named GCNMDA. In the hidden layer of GCN, we further exploited the Conditional Random Field (CRF), which can ensure that similar nodes (i.e., microbes or drugs) have similar representations. To more accurately aggregate representations of neighborhoods, an attention mechanism was designed in the CRF layer. Moreover, we performed a random walk with restart (RWR) based scheme on both drug and microbe similarity networks to learn valuable features for drugs and microbes respectively. Experimental results on three different datasets showed that our GCNMDA model consistently achieved better performance than seven state-of-the-art methods. Case studies for three microbes including SARS-CoV-2 and two antimicrobial drugs (i.e., Ciprofloxacin and Moxifloxacin) further confirmed the effectiveness of GCNMDA in identifying potential microbe-drug associations.

Availability

Python codes and dataset are available at: https://github.com/longyahui/GCNMDA.

Supplementary information

Supplementary data are available at Bioinformatics online.